Todos os pacientes com doença inflamatória intestinal devem ser rastreados para colangite esclerosante primária.[52]Navaneethan U, Shen B. Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease. Inflamm Bowel Dis. 2010 Sep;16(9):1598-619.
https://academic.oup.com/ibdjournal/article/16/9/1598/4628472
http://www.ncbi.nlm.nih.gov/pubmed/20198712?tool=bestpractice.com
[53]Belle A, Laurent V, Pouillon L, et al. Systematic screening for primary sclerosing cholangitis with magnetic resonance cholangiography in inflammatory bowel disease. Dig Liver Dis. 2018 Oct;50(10):1012-18.
https://www.doi.org/10.1016/j.dld.2018.06.024
http://www.ncbi.nlm.nih.gov/pubmed/30076016?tool=bestpractice.com
O uso deste conteúdo está sujeito ao nosso aviso legal